AAHPM Assembly State of the Science 2015

As David Currow said when he received his Excellence in Research award, hospice and palliative medicine researchers need to meticulously measure toxicity in addition to benefits of palliative interventions. How do you think the State of the Science studies did with this goal? What do you think about the conclusions of each of the studies? Any changes in your practice? Thanks to the presenters Jay Horton, Kimberly Johnson,Nick Dionne-Odom, and Cardinale Smith for reviewing and presenting. Always a fun presentation.

Neurolytic sympathectomy in management of cancer pain-time effect: a prospective, randomized multicenter study http://t.co/fdqI1A2meB #hpm15

— Lyle Fettig (@lfettig) February 28, 2015

Comparative effectiveness-senna to prevent problematic constipation in peds onc patients receiving opioids:http://t.co/rYyx3xY7jI #hpm15

— Lyle Fettig (@lfettig) February 28, 2015

Randomized Controlled Trial of Expressive Writing for Patients With Renal Cell Carcinoma http://t.co/2reY7q5CM0 #hpm15

— Lyle Fettig (@lfettig) February 28, 2015

Safety of benzodiazepines and opioids in very severe respiratory disease: national prospective study http://t.co/CsbkLEa0jF #hpm15

— Lyle Fettig (@lfettig) February 28, 2015

An integrated palliative and respiratory care service for patients with advanced disease: An RCT http://t.co/awhOMOKRAy #hpm15

— Lyle Fettig (@lfettig) February 28, 2015

Inpatient palliative care for patients with acute heart failure: outcomes from a randomized trial. http://t.co/HCRVaXRIw4 #hpm15

— Lyle Fettig (@lfettig) February 28, 2015

Intervention to improve care at life's end in inpatient settings: the BEACON trial. http://t.co/Ht7MwhzIYF #hpm15

— Lyle Fettig (@lfettig) February 28, 2015

Association of experience with illness and end-of-life care with advance care planning in older adults http://t.co/S04ifi57iM #hpm15

— Lyle Fettig (@lfettig) February 28, 2015